Research Alliance II's common stock is $150M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
Research Alliance II (RACB) currently reports a common stock of $150M as of September 2022. That compares with $150M in the prior-year period — up 0.5% year over year. Use the charts on this page to explore Research Alliance II's common stock history and peer comparisons.
Research Alliance II's common stock increased from $150M to $150M — a 0.5% year-over-year increase (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Research Alliance II reported $150M in common stock as of September 2022. That compares with $150M in the prior-year period — up 0.5% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current common stock of $150M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Research Alliance II, and consider following RACB for alerts when major investors trade the stock.